FCCC LOGO Faculty Publications
Somaiah N , von Mehren M
New therapeutic approaches for advanced gastrointestinal stromal tumors
Hematol Oncol Clin North Am. 2009 Feb;23(1) :139-50
PMID: 19248977    PMCID: PMC2861350   
Back to previous list
Abstract
The management of advanced gastronintestinal stromal tumor is increasingly complex because of imatinib refractory disease. Primary resistance to imatinib is uncommon, and most patients progress after development of additional genetic changes. This article reviews management strategies including surgical approaches, local modalities for progressive liver metastases, as well as novel therapeutic agents.
Notes
Somaiah, Neeta von Mehren, Margaret United States Hematology/oncology clinics of North America Hematol Oncol Clin North Am. 2009 Feb;23(1):139-50.